will immunotherapy take over the treatment landscape of patients high-risk renal cell carcinoma?
Published 2 years ago • 417 plays • Length 0:48Download video MP4
Download video MP3
Similar videos
-
5:12
renal cell carcinoma trial analysis: current landscape of immunotherapy combinations
-
0:35
potential of immunotherapy for kidney cancer
-
5:11
current treatment landscape for kidney cancer
-
1:34
unmet needs in the treatment of renal cell carcinoma
-
0:59
decreasing the risk of immunotherapy-related kidney damage
-
4:15
the unmet needs of kidney cancer treatment
-
3:04
success of novel immunotherapies for renal cell carcinoma
-
2:53
immunotherapy and targeted therapy for advanced arcc
-
0:29
hope for the future of kidney cancer treatment
-
0:58
how can we improve outcomes for patients with kidney cancer who receive immunotherapy?
-
3:31
perioperative strategies in high-risk and oligometastatic renal cell and urothelial cancers
-
0:55
the emerging continuum of care in metastatic kidney cancer in the second-line and beyond
-
2:33
immunotherapy for lung cancer: current landscape and challenges
-
5:18
are combination therapies the future of renal cell carcinoma treatment?
-
2:21
first-line treatment decision making for patients with rcc
-
5:25
the current treatment landscape for mcc
-
1:51
the evolving first-line treatment landscape for advanced rcc
-
5:16
potential new treatments in renal cell carcinoma
-
1:03
potential of adjuvant therapy for rcc